Why the study?
Limited evidence exists regarding the consistent and synergistic benefits of early rhythm control and healthy lifestyle on major adverse cardiovascular events in young patients with atrial fibrillation.
Does early rhythm control and healthy lifestyle reduce major adverse cardiovascular events in young patients with new-onset atrial fibrillation?
Does early rhythm control and healthy lifestyle reduce major adverse cardiovascular events in young patients with new-onset atrial fibrillation?
In young patients with new-onset atrial fibrillation, combining early rhythm control with healthy lifestyle behaviors synergistically reduces the risk of major adverse cardiovascular events.
Answers are grounded in this paper and cite their sources.
Supports combined early rhythm control plus lifestyle in new-onset AF; hypothesis-generating and requires randomized confirmation.
BACKGROUND: Limited evidence exists regarding the consistent and synergistic benefits of early rhythm control (ERC) and healthy lifestyle (HLS) on major adverse cardiovascular events (MACEs) in young patients with atrial fibrillation (AF). AIMS: To evaluate the individual and synergistic benefits of ERC and HLS on MACEs in young AF patients. METHODS: In an observational cohort study using a Korean nationwide claims database, new-onset AF patients (age 20-<65 years) were included. ERC was defined as rhythm control treatment within 2 years of AF diagnosis, and HLS as having at least two healthy lifestyle behaviours (quitting smoking/abstaining from alcohol/regular exercise). Patients were grouped into: without ERC and HLS (n = 28,809); HLS alone (n = 41,827); ERC alone (n = 10,962); and both ERC and HLS (n = 16,594). The primary outcome was MACEs, and the secondary outcomes included ischaemic stroke, myocardial infarction, heart failure hospitalisation and all-cause death. Multivariable Cox regression analysis assessed HR for MACEs. The ERC and HLS groups were significantly associated with a lower risk of MACEs (ERC: HR .765; 95% CI .722-.810, p < .001 and HLS: HR .813, 95% CI .770-.860, p < .001) compared to those without ERC and HLS; both the ERC and HLS groups were associated with the lowest risk of MACEs (HR .616, 95% CI .569-.666, p < .001). Similar trends were observed for ischaemic stroke among secondary outcomes. CONCLUSIONS: ERC and HLS were individually and synergistically associated with a significantly lower risk of MACEs in young AF patients.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: